We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7B
AUM Growth
+$217M
Cap. Flow
-$14.5M
Cap. Flow %
-0.21%
Top 10 Hldgs %
60.82%
Holding
146
New
18
Increased
42
Reduced
35
Closed
13

Top Buys

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$296M
2
MCK icon
McKesson
MCK
+$216M
3
ABBV icon
AbbVie
ABBV
+$15.7M
4
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$15.3M
5
BIDU icon
Baidu
BIDU
+$10.5M

Sector Composition

Rank Sector Weight
1 Financials 32.87%
2 Healthcare 23.56%
3 Communication Services 16.37%
4 Consumer Discretionary 11.94%
5 Materials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MD icon
76
Pediatrix Medical
MD
$2.18B
$2.54M 0.04%
34,962
VRTX icon
77
Vertex Pharmaceuticals
VRTX
$121B
$2.52M 0.04%
21,400
-500
-2% -$59.9K
LO
78
DELISTED
LORILLARD INC COM STK
LO
$2.42M 0.03%
37,000
-4,000
-10% -$266K
PTLA
79
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.35M 0.03%
62,013
+25,000
+68% +$859K
TEVA icon
80
Teva Pharmaceuticals
TEVA
$40.8B
$2.24M 0.03%
36,000
KTWO
81
DELISTED
K2M Group Holdings, Inc
KTWO
$2.23M 0.03%
101,151
KITE
82
DELISTED
Kite Pharma, Inc.
KITE
$2.1M 0.03%
+35,000
New +$2.35M
MA icon
83
Mastercard
MA
$502B
$2.07M 0.03%
24,000
-9,000
-27% -$781K
ASXC
84
DELISTED
Asensus Surgical, Inc.
ASXC
$1.87M 0.03%
49,013
+23,077
+89% +$871K
INNL
85
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$1.84M 0.03%
245,184
RPRX
86
DELISTED
Repros Therapeutics Inc.
RPRX
$1.72M 0.02%
200,000
+65,000
+48% +$581K
OXFD
87
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.7M 0.02%
120,460
+20,000
+20% +$272K
LMNS
88
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$1.66M 0.02%
139,014
+82,652
+147% +$897K
CRDF icon
89
Cardiff Oncology
CRDF
$66.5M
$1.63M 0.02%
3,314
+973
+42% +$415K
ASPX
90
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$1.55M 0.02%
15,500
-82,421
-84% -$5.49M
REGN icon
91
Regeneron Pharmaceuticals
REGN
$78.5B
$1.51M 0.02%
3,350
-250
-7% -$106K
CARM
92
DELISTED
Carisma Therapeutics
CARM
$1.49M 0.02%
8,372
+5,000
+148% +$1.09M
AEGR
93
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.46M 0.02%
55,940
ATEC icon
94
Alphatec Holdings
ATEC
$1.46B
$1.29M 0.02%
74,052
ALXA
95
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$829K 0.01%
400,273
LUMO
96
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$711K 0.01%
+1,444
New +$560K
ACOR
97
DELISTED
Acorda Therapeutics
ACOR
$532K 0.01%
133
TD icon
98
Toronto Dominion Bank
TD
$198B
$522K 0.01%
9,620
+2,300
+31% +$98.8K
SCI icon
99
Service Corp International
SCI
$11.7B
$461K 0.01%
17,700
QIWI
100
DELISTED
QIWI PLC
QIWI
$429K 0.01%
17,875

Similar funds

C WorldWide Group's Q1 2015 Portfolio in Review

As of Q1 2015, C WorldWide Group held 146 positions worth $7B, up 3.2% from $6.79B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

C WorldWide Group's Q1 2015 filing shows 18 new, 42 increased, 35 reduced and 13 closed positions. Its largest new stake was Ecolab: 2,697,311 shares worth $309M. The largest sale was Microsoft, an estimated $414M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.

  • C WorldWide Group's largest Q1 2015 buy was Ecolab: 2,697,311 shares worth $309M.
  • C WorldWide Group added most to McKesson in Q1 2015, an estimated $216M increase.
  • C WorldWide Group's biggest Q1 2015 reduction was Visa, cutting an estimated $19.1M.
  • C WorldWide Group fully exited Microsoft in Q1 2015, selling an estimated $414M.
  • C WorldWide Group's ten largest holdings make up 61% of its $7B portfolio in Q1 2015.
  • C WorldWide Group opened 18 new positions and closed 13 in Q1 2015.
  • C WorldWide Group's portfolio value rose 3.2% quarter-over-quarter to $7B.

Based on C WorldWide Group's 13F filing for Q1 2015, filed 13 May 2015.